ARCT
NASDAQ · Biotechnology
Arcturus Therapeutics Holdin
$8.31
-0.05 (-0.60%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+217.8% upside
Low Target
$16.23
Average Target
$26.41
High Target
$33.18
Current Price
$8.31
Current
$8.31
$8.31
Target
$26.41
$26.41
$16.23
$26.41 avg
$33.18
Scenario Analysis
Bear Case
$16.23
95.3%
Low target
Base Case
$26.41
+217.8%
Avg target
Bull Case
$33.18
+299.3%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$17.96
-53.7% from high
52-Week Low
$5.50
+51.1% from low
Target vs 52W High
$26.41
+47.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.2% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +114.1% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -17.6% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -30.6% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -50.5% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -31.6% |